Schizophrenia, Substance Abuse, Migraines, Pain Flashcards
Kappa receptor effects
dec. GI sedation dysphoria psychosis
A delta fibers -myelination -conduction -respond to what
thinly myelinated –conduction=20m/sec respond to noxious mechanical stimuli
Cox 1 location
most tissues
Full effects SZP time and symptoms
12 weeks ADLS cognition - symptoms delusions
Origins of Neuropathic pain
peripheral -abnormal nocicpetor sensitization -dec. threshold -inc. sensitivity to afferent neurons central -central sensitization of nociceptors
Atypical AP high affinity for?
5HT2
T/F priamry nociceptive neurons have smaller diameter axons
true –slower conduction speed
FGA/SGA potency and Ach?
low: most sedating Med: medium sedation High: least sedating
FGA med. potency
Loxapine Perhenazine Thiotixene
drug w/ QTc prolongation risk
ziprasidone
Step 2 Who ladder
Mild-Mod opoids +/- non opioids +/- adjuvant
CIWA scores
0-9 very mild withdrawal 10-15 mild 16-20 modest 21-67 severe
Baseline monitoring parameters (11) SZP
BP BMI waist circumference A1C fasting lipid panel CMP CBBC TSH EKG pregnancy aims
Who ladder step 1
non-opioids +/- adjuvant
urine screen metabolites of oxycodone
oxycodone oxymorphone
Dystonia risks (3)
treatment naive elderly FGA
TX of - symp in SZP
max antipsychotic Add antidepressant
SGA high potency
Risperidone Paliperidone
akathesia tx (4)
anti-parkinson BB BZD dec. dose
How long does meth stay in urine
1-2 days
Tension Tx prophylactic
Amitriptyline
buprenorphine MOA
partial agonist at mu receptor weak kappa antagonist
urine screen metabolites of codeine
codeine morphine hydrocodone
Mod-Severe opioids (6)
morphine oxycodone dulaudid opana duragesic methadone
Moderate response time and symptoms on SZP
4-6 weeks + symptoms ADL
naloxegol MOA
Mu in Gi antagonist
lurasidone major counsel
must take w/ >350cal
seizure risk in AP highest?
clozapine
alpha 1 antagonism in SZP (2)
sedation hypotension
how long does methadone stay in urine
3 days
Tension Type HA Dx(3)
bilateral not aggravated by acitivites no nausea
ETOH dependence TX
Disulfiram
Reduce ETOH craving
Naltrexone Acamprosate
GHB MOA
weak GABA-B agonist and GHB receptor agonist -open K channel -close Ca channels dec. neuronal acitivation and NT release
Define Dependence
removal of the drug results in withdrawal symptoms which can be physical or psychological
opioid function of respiratory depression
dec in sensitivity of respiratory center to CO2
drugs w/ high risk of EPS (2)
haldol risperidone -b/c high potency FGA: b/c slow dissociation
A beta afferent fibers cause
allodynia
opioid use when are pupils large/small
intoxication: pinpoint withdrawal: enlarged over dose: ppinpoint
t/f opioid constipation is easier to treat than prevent
F
Dephenylheptane Class
Methadone
sizure risk in AP lowest?
quetiapine
SGA low potency
Clozapine Quetiapine
Define Addiction
uncontrollable, compulsive drug seeking and use, even in the face of negative health or social consequences
How long does codeine stay in urine
48 hrs
What is the potent metabolite of THC
11-hydroxy-THC
TX insomnia in SZP (4)
antihistamine sedating antidepressant -trazodone -mirtazapine -doxepin hypnotics BZD
urine screen metabolites of alprazolam
alpha hydroxyalprazolam
CGRP receptor blockers (2)
Erenumab Fremanezumab
Balbenzine Deutetetrabenzine MOA
vesicular monoamine transporter 2 inhibitors
which HA respond to indomethacin (5)
stabbing hemicrania exercise HA cough HA sexual activity HA
Preprodynorphin cleaved to what
Dynorpin
Tardive dyskinesia risk (4)
middle aged women elderly long-term use FGAs high dose/potency
Is a immunoassay urine drug screen qualitative/quantitative
Qualitative
iloperidone major counsel
miss >3 days must re titrate
Acamprosate counsel
crcl 30-50 dose 333 TID Crcl <30 do not use continue use if relapse
Delta receptor effects
immune modulation
reason naloxegol stays in GI
PEG chain
Triptan contraindication (3)
CAD CVD uncontrolled HTN
Neuropathic pain 1st line TX
Secondary amines -Nortriptyline -Amitriptyline Ca channel Ligans -Pregabalin -Gabapentin SNRI -Duloxetine Venlafaxine
pain classification
existential physical -malignant -nonmalignant –neuropathic –nocicpetive —chronic —acute —-mild/mod/severe
Preproenkephalin cleaved to what?
Met-enkephalin Leu-Enkephalin
Cluster HA age of onset
3rd generation
Mild-Mod opioids (2)
Vicodin Percocet
MOH trigger
analgesic use >3 times/wk
Naltrexone major counsel
do not use if ALT/AST 3x UL wait until 7-10 days opioid free
how long does alcohol stay in urine
1-12 hrs
alcohol MOA
stimulation of GABA-A receptors -dec. neuronal firing inhibit NMDA -supress neuronal activity
cluster HA Tx (2) prophylactic
lithium CCB
Which one Pos. or Neg have good meausre/snapshot of disease control and which part
positive -disorganized
T/F SZP have decreased brain volume
True
Tapentadol lMOA
Mu agonist Ne reuptake inhibit
SZP what do you do to dose when you hit maintenance
same dose or slightly decrease dose
Disulfiram monitoring
LFT cardiac tests
Migraine acute tx (5)
analgesics caffeine Narcotics DHE Triptan
CIWA-AR definition
clinical instisute withdrawal assessment
Naltrexone MOA
competeive antagonist at opioid receptor
Migraine Diagnosis
5 attacks w/ all: last 4-72 hours Has 2 of following: -unilateral -pulsating -mod/severe pain -aggravation by activity During has one of this: -N/V -photo/phonophobia
2 opioids w/ highest pruritus
morphine hydromorphone
Abrupt D/c drugs that cause risks? (3)
clozapine quetiapine iloperidone
w/d cannabis DX
3+ irritably anxiety weight loss restlessness depressed
cluster HA triggers
alcohol tobacco
Gamma hydroxybutyrate (GHB) what is it
precursor and metabolite of GABA
pseudoparkinsonism risk (3)
women >40 FGA
2 types of nociceptive pin
somatic visceral
how long does heroin stay in urine
48 hours as morphine
TX of agression/hositility/mania in SZP (4)
lithium DVP CBZ LMG
common ending for atypical AP
done pine azole
stimulation of A delta and C fibers result in
excitatory transmission in dorsal horn neurons triggers NMDA causing long lasting excitability of dorsal horn neurons
Naloxegol indication
opioid constipation
positive symp. SZP
hallucinations
delusions
thought disorders
disorganized behavior:
*agitation,
*incongruency,
*ADLs
impaired speech: tangentiality, circumstantiality, derailment bizarre behavior i
nsomnia
combativeness
when does adensoine dec and inc?
dec. during slow wave sleep inc. after prolonged wakefulness
Cox 2 induction
in tissues and inflammatory cells in response to inflammation and pain
suboxone dose day 1 and 2
8-2 day 1 16-4 days 2
methadone MOA (3)
strong mu agonist nmda antagonist 5ht/Ne reuptake inhibitor
A1 function
inhibiton of adenylate cyclase
CB1 signalling MOA
inhibit adenylate cyclate -inhibit Ca channel activation -K channel activation
opioid dependence TX
buprenorphine +/- nalonxone
inc. prolactin inc risk (3)
FGA risperidone paliperidone